精优药业(00858)发布盈喜公告，预计截至2025年3月31日止年度将实现净利润约2.15亿港元至2.25亿港元，成功扭亏为盈。这一显著的业绩改善主要归因于非现金项目的收益，具体来说是由于按公平值计入损益的金融资产（即集团可换股债券投资）的公平值变动产生的收益。相比之下，去年同期该非现金项目则出现了公平值变动的亏损。此次盈利转变标志着公司在财务表现上取得了重大进展。
Source Link精优药业(00858)发布盈喜公告，预计截至2025年3月31日止年度将实现净利润约2.15亿港元至2.25亿港元，成功扭亏为盈。这一显著的业绩改善主要归因于非现金项目的收益，具体来说是由于按公平值计入损益的金融资产（即集团可换股债券投资）的公平值变动产生的收益。相比之下，去年同期该非现金项目则出现了公平值变动的亏损。此次盈利转变标志着公司在财务表现上取得了重大进展。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.